China SXT Pharmaceuticals shares surge 30.43% after-hours on AI supply chain initiative and market analysis expansion.

China SXT Pharmaceuticals, Inc. (SXTC) surged 30.43% in after-hours trading following the announcement by Univest Securities, LLC that it had closed a $10 million registered direct offering for the company. The financing, part of a strategic initiative to apply AI technology across its Traditional Chinese Medicine (TCM) supply chain and develop AI-supported clinics, signals a significant capital infusion to advance its digital transformation and market expansion plans. The transaction, executed under an effective shelf registration statement, likely bolstered investor confidence in the company’s operational and technological growth trajectory, directly aligning with the sharp after-hours price increase.